Funding Shortfall in Multi-Employer Plans
First written in FY2017. 4 of 9 entries say "Mitigated", first in FY2022. Latest entry: FY2026.
Sankyo Kasei moved to the "Worse" side of this theme in 2018, the same year as the typical company in this theme.
The whole theme swung hardest in 2024: 3 of 9 companies on the "Worse" side.
8 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Net amount △¥21,098.797 million」
The underfunded amount for the multi-employer plan as a whole decreased from ¥21,578.478 million in the previous fiscal year to ¥21,098.797 million. - FY2025MitigatedAnnual report
「Net amount △¥21,578.478 million」
The underfunded amount for the multi-employer plan as a whole decreased from the previously disclosed ¥25,918.968 million to ¥21,578.478 million. - FY2024WorsenedAnnual report
「Net amount △¥25,593.718 million Net amount △¥25,918.968 million」
The underfunded amount for the multi-employer plan as a whole increased from the previously disclosed ¥25,593.718 million to ¥25,918.968 million. - FY2023MitigatedAnnual report
「Net amount △¥25,593.718 million」
The underfunded amount for the multi-employer plan as a whole decreased from the previously disclosed ¥26,547.417 million to ¥25,593.718 million. - FY2022MitigatedAnnual report
「Net amount △¥26,547.417 million」
The underfunded amount for the multi-employer plan as a whole decreased from the previously disclosed ¥30,315.032 million to ¥26,547.417 million. - FY2020Underfunding in the multi-employer plan disclosed againAnnual report
「Net amount △¥30,315.032 million」
The Company disclosed an underfunded amount of ¥30,315.032 million for the multi-employer plan as a whole as of 31 March 2019. The disclosure states that the contribution ratio was 0.38% and the remaining amortization period was 24 years and 8 months. - FY2019SoftenedAnnual report
「The disclosure has been omitted because the amount had not been finalized as of the latest reporting date.」
Specific details of the underfunded amount were omitted because the amounts relating to the funding status of the multi-employer plan as a whole and the contribution ratio had not been finalized. - FY2018WorsenedAnnual report
「Net amount △¥67,117.338 million」
The underfunded amount of the Osaka Pharmaceutical Industry Employees' Pension Fund increased from the previously disclosed ¥58,997.780 million to ¥67,117.338 million. Meanwhile, the fund was dissolved on 28 March 2018 and transferred to its successor, the Osaka Pharmaceutical Industry Corporate Pension Fund, and no additional contributions are expected to arise. - FY2017First statedAnnual report
「Net amount △¥58,997.780 million」
As of 31 March 2016, the Company disclosed an underfunded amount of ¥58,997.780 million, representing the difference between the amount of pension assets under the multi-employer plan and the combined amount of actuarial liabilities and minimum liability reserves.